NRG-GU006 at the 2025 ASTRO Clinical Trials Session

from The NRG Oncology Podcast · host NRG Oncology

Our co-hosts discuss NRG-GU006 with Dr. Daniel Spratt. The results of NRG-GU006, a phase II clinical study in recurrent prostate cancer, were presented as a part of the 2025 American Society for Radiation Oncology (ASTRO) Annual Meeting Clinical Trials Session.

Episode metadata supplied by the publisher feed · Published Sep 28, 2025

Embed this episode

Attribution link and audio player

NOW PLAYING

NRG-GU006 at the 2025 ASTRO Clinical Trials Session

0:00 36:14

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The NRG Oncology Podcast?

This episode is 36 minutes long.

When was this The NRG Oncology Podcast episode published?

This episode was published on September 28, 2025.

Can I download this The NRG Oncology Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!